Deregulated expression of hnRNP A/B proteins in human non-small cell lung cancer: Parallel assessment of protein and mRNA levels in paired tumour/non-tumour tissues

BMC Cancer

Volumn 10, Issue , 2010, Pages

  Boukakis, Georgios ^a   Patrinou Georgoula, Meropi ^a   Lekarakou, Maria ^b   Valavanis, Christos ^b   Guialis, Apostolia ^a  

^a INSTITUTE OF BIOLOGY   (Greece)

^b METAXA CANCER HOSPITAL   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN A1; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN A2; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN A3; MESSENGER RNA; NUCLEAR PROTEIN; SF2 PROTEIN; UNCLASSIFIED DRUG; HNRNP A1; HNRNPA3 PROTEIN, HUMAN; RNA BINDING PROTEIN; SERINE ARGININE RICH SPLICING PROTEINS; SERINE-ARGININE-RICH SPLICING PROTEINS;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG NON SMALL CELL CANCER; MALE; TISSUE FIXATION; TISSUE HOMOGENATE; TUMOR BIOPSY; UPREGULATION; WESTERN BLOTTING; ADENOCARCINOMA; CANCER STAGING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; ENZYME IMMUNOASSAY; GENETICS; LARGE CELL CARCINOMA; LUNG; LUNG ALVEOLUS CELL CARCINOMA; LUNG TUMOR; LYMPH NODE METASTASIS; METABOLISM; METASTASIS; MIDDLE AGED; PATHOLOGY; RANDOMIZED CONTROLLED TRIAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SQUAMOUS CELL CARCINOMA; SURVIVAL RATE; TREATMENT OUTCOME;

ADENOCARCINOMA; ADENOCARCINOMA, BRONCHIOLO-ALVEOLAR; AGED; BLOTTING, WESTERN; CARCINOMA, LARGE CELL; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SQUAMOUS CELL; FEMALE; HETEROGENEOUS-NUCLEAR RIBONUCLEOPROTEIN GROUP A-B; HUMANS; IMMUNOENZYME TECHNIQUES; LUNG; LUNG NEOPLASMS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM STAGING; NUCLEAR PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA-BINDING PROTEINS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 77955526422     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-10-434     Document Type: Article

References (42)

1. Glisovic T, Bachoric JL, Yong J, Dreyfuss G. RNA-binding proteins and post-transcriptional gene regulation. FEBS Lett 2008, 582:1977-1986. 10.1016/j.febslet.2008.03.004, 2858862, 18342629.
2. Krecic AM, Swanson MS. hnRNP complexes: composition, structure, and function. Curr Opin Cell Biol 1999, 11:363-371. 10.1016/S0955-0674(99)80051-9, 10395553.
3. Dreyfuss G, Kim VN, Kataoka N. Messenger-RNA-binding proteins and the messages they carry. Nat Rev Mol Cell Biol 2002, 3:195-205. 10.1038/nrm760, 11994740.
4. He Y, Brown MA, Rothnagel JA, Saunders NA, Smith R. Roles of heterogeneous nuclear ribonucleoproteins A and B in cell proliferation. J Cell Science 2005, 118:3173-3183. 10.1242/jcs.02448, 16014382.
5. Carpenter B, MacKay C, Alnabulsi A, MacKay M, Telfer C, Melvin WT, Murray GI. The roles of heterogeneous nuclear ribonucleoproteins in tumour development and progression. Biochim Biophys Acta 2006, 1765:85-100.
6. Perotti D, Neviani P. From mRNA metabolism to cancer therapy: chronic myelogenous leukemia shows the way. Clin Cancer Res 2007, 13:1638-1642. 10.1158/1078-0432.CCR-06-2320, 17363515.
7. Dreyfuss G, Matunis JM, Pinol-Roma S, Burd GC. hnRNP proteins and the biogenesis of mRNA. Annu Rev Biochem 1993, 62:289-321. 10.1146/annurev.bi.62.070193.001445, 8352591.
8. Burd CG, Dreyfuss G. Conserved structures and diversity of functions of RNA binding proteins. Science 1994, 265:615-621. 10.1126/science.8036511, 8036511.
9. Burd CG, Swanson MS, Gorlach M, Dreyfuss G. Primary structures of the heterogeneous nuclear ribonucleoprotein A2, B1 and C2 proteins: a diversity of RNA binding proteins is generated by small peptide inserts. Proc Natl Acad Sci 1989, 86:9788-9792. 10.1073/pnas.86.24.9788, 298587, 2557628.
10. Kozu T, Henrich B, Schafer KP. Structure and expression of the gene (HNRNPA2B1) encoding the human hnRNP protein A2/B1. Genomics 1995, 25:365-371. 10.1016/0888-7543(95)80035-K, 7789969.
11. Kamma H, Horiguchi H, Wan L, Matsui M, Fujiwara M, Fujimoto M, Yazawa T, Dreyfuss G. Molecular characterization of the hnRNP A2/B1 proteins: Tissue-specific expression and novel isoforms. Exp Cell Res 1999, 246:399-411. 10.1006/excr.1998.4323, 9925756.
12. Hanamura A, Caceres JF, Mayeda A, Franza BR, Krainer AR. Regulated tissue-specific expression of antagonistic pre-mRNA splicing factors. RNA 1998, 4:430-444. 1369629, 9630249.
13. Ghigna C, Moroni M, Porta C, Riva S, Biamonti G. Altered expression of heterogeneous nuclear ribonucleoproteins and SR factors in human colon adenocarcinomas. Cancer Res 1998, 58:5818-5824.
14. Zerbe LK, Pino I, Pio R, Cosper PF, Dwyer-Nield LD, Meyer AM, Port JD, Montuenga LM, Malkinson AM. Relative amounts of antagonistic splicing factors, hnRNP A1 and ASF/SF2, change during neoplastic lung growth; implications for pre-mRNA processing. Mol Carcinog 2004, 41:187-196. 10.1002/mc.20053, 15390079.
15. Kamma H, Portman DS, Dreyfuss G. Cell type-specific expression of hnRNP proteins. Exp Cell Res 1995, 221:187-196. 10.1006/excr.1995.1366, 7589244.
16. Montuenga LM, Zhou J, Avis I, Vos M, Martinez A, Cuttitta F, Treston AM, Sunday M, Mulshine JL. Expression of heterogeneous nuclear Ribonucleoprotein A2/B1 changes with critical stages of mammalian lung development. Am J Respir Cell Mol Biol 1998, 19:554-562.
17. Patry C, Bouchard L, Labrecque P, Gendron D, Lemieux B, Toutant J, Lapointe E, Wellinger R, Chabot B. Small interfering RNA-mediated reduction in heterogeneous nuclear ribonucleoparticule A1/A2 proteins induces apoptosis in human cancer cells but not in normal mortal cell lines. Cancer Res 2003, 63:7679-7688.
18. Ostrowski J, Bomsztyk K. Nuclear shift of hnRNP K protein in neoplasms and other states oh enhanced cell proliferation. Br J Cancer 2003, 89:1493-1501. 10.1038/sj.bjc.6601250, 2394341, 14562022.
19. Tockman MS, Mulshine JL, Piantadosi S, Erozan YS, et al. Prospective detection of preclinical lung cancer: Results from two studies of heterogeneous nuclear ribonucleoprotein A2/B1 overexpression. Clin Cancer Res 1997, 3:2237-2246.
20. Zhou J, Mulshine JL, Unsworth EJ, Scott FM, Avis IM, Vos MD, Treston AM. Purification and characterization of a protein that permits early detection of lung cancer. Identification of hnRNP A2/B1 as the antigen for monoclonal antibody 703D4. J Biol Chem 1996, 271:10760-10766. 10.1074/jbc.271.18.10760, 8631886.
21. Man YG, Martinez A, Avis IM, Hong SH, Cuttitta F, Venzon D, Mulshine JL. Phenotypically different cells with heterogeneous nuclear ribonucleoprotein A2/B1 overexpression show similar genetic alterations. Am J Respir Cell Mol Biol 2000, 23:636-645.
22. Zhou J, Nong L, Wloch M, Cantor A, Mulshine JL, Tockman MS. Expression of early lung cancer detection marker: hnRNP-A2/B1 and its relation to microsatellite alteration in non-small cell lung cancer. Lung Cancer 2001, 34:341-350. 10.1016/S0169-5002(01)00254-9, 11714531.
23. Satoh H, Kamma H, Ishikawa H, Horiguchi H, Fujiwara M, Yamashita YT, Ohtsuka M, Sekizawa K. Expression of hnRNP A2/B1 proteins in human cancer cell lines. Int J Oncol 2000, 16:763-767.
24. Sueoka E, Goto Y, Sueoka N, Kai Y, Kozu T, Fujiki H. Heterogeneous nuclear ribonucleoprotein B1 as a new marker of early detection for human lung cancers. Cancer Res 1999, 59:1404-1407.
25. Sueoka E, Sueoka N, Goto Y, Matsuyama S, Nishimura H, Sato M, Fujimura S, Chiba H, Fujiki H. Heterogeneous nuclear ribonucleoprotein B1 as early cancer biomarker for occult cancer of human lungs and bronchial dysplasia. Cancer Res 2001, 61:1896-1902.
26. Wu S, Sato M, Endo C, Sakurada A, Dong B, Aikawa H, Chen Y, Okada Y, Matsumura Y, Sueoka E, Kondo T. hnRNP B1 protein may be a possible prognostic factor in squamous cell carcinoma of the lung. Lung Cancer 2003, 41:179-186. 10.1016/S0169-5002(03)00226-5, 12871781.
27. Tominaga M, Sueoka N, Irie K, Iwanaga K, Tokunaga O, Hayashi S-I, Nakachi K, Sueoka E. Detection and discrimination of preneoplastic and early stages of lung adenocarcinoma using hnRNP B1 combined with the cell cycle-related markers p16, cyclin D1 and Ki-67. Lung cancer 2003, 40:45-53. 10.1016/S0169-5002(02)00529-9, 12660006.
28. Snead DRJ, Perunovic B, Cullen N, Needham M, Dhillon DP, Satoh H, Kamma H. hnRNP B1 expression in benign and malignant lung. J Pathol 2003, 200:88-94. 10.1002/path.1292, 12692846.
29. Zech VFE, Dlaska M, Tzankov A, Hilbe W. Prognostic and diagnostic relevance of hnRNP A2/B1, hnRNP B1 and S100 A2 in non-small cell lung cancer. Cancer Detect Prev 2006, 30:395-402. 10.1016/j.cdp.2006.04.009, 17067748.
30. Pino I, Pio R, Toledo G, Zabalegui N, Vicent S, Rey N, Lozano MD, Torre W, Garcia-Foncillas J, Montuenga LM. Altered patterns of expression of members of the heterogeneous nuclear ribonucleoprotein (hnRNP) family in lung cancer. Lung Cancer 2003, 41:131-143. 10.1016/S0169-5002(03)00193-4, 12871776.
31. Yan-Sanders Y, Hammons GJ, Lyn-Cook RD. Increased expression of heterogeneous nuclear ribonucleoprotein A2/B1 (hnRNP) in pancreatic tissue from smokers and pancreatic tumor cells. Cancer Lett 2002, 183:215-220. 10.1016/S0304-3835(02)00168-4, 12065097.
32. Meuwissen R, Berns A. Mouse models for human lung cancer. Genes Dev 2005, 19:643-664. 10.1101/gad.1284505, 15769940.
33. Zhou J, Mulshine JL, Ro JY, Avis I, Yu R, Lee J, Morice R, Lippman SM, Lee JS. Expression of heterogeneous nuclear ribonucleoprotein A2/B1 in bronchial epithelium of chronic smokers. Clin Cancer Res 1998, 4:1631-1640.
34. Fielding P, Turnbull L, Prime W, Walshaw M, Field JK. Heterogeneous nuclear ribonucleoprotein A2/B1 up-regulation in bronchial lavage specimens: a clinical marker of early lung cancer detection. Clin Cancer Res 1999, 5:4048-4052.
35. Hamasaki M, Kamma H, Wu W, Kaneko S, Fujiwara M, Satoh H, Haraoka S, Kikuchi M, Shirakusa T. Expression of hnRNP B1 in four major histological types of lung cancers. Anticancer Res 2001, 21:979-984.
36. Katsimpoula S, Patrinou-Georgoula M, Makrilia N, Dimakou K, Guialis A, Orfanidou D, Syrigos KN. Overexpression of hnRNP A2/B1 in bronchoscopic speciments: a potential early detection marker in lung cancer. Anticancer Res 2009, 29:1373-1382.
37. Ushigome M, Ubagai T, Fukuda H, Tsuchiya N, Sugimura T, Takatsuka J, Nakagama H. Up-regulation of hnRNP A1 gene in sporadic human colorectal cancers. Int J Oncol 2005, 26:635-640.
38. Peebles KA, Dwyer-Nield LD, Malkinson AM. Altered expression of splicing factor, heterogeneous nuclear ribonucleoprotein A2/B1, in mouse lung neoplasia. Mol Carcinog 2007, 46:887-900. 10.1002/mc.20321, 17477362.
39. Gygi SP, Rochon Y, Franza BR, Aebersold R. Correlation between protein and mRNA abundance in yeast. Mol Cell Biol 1999, 19:1720-1730. 83965, 10022859.
40. Mazan-Mamczarz K, Gartenhaus RB. Post-transcriptional control of the MCT-1-associated proetin DENR/DRP by RNA-binding protein AUF1. Cancer Genomics Proteomics 2007, 4:233-239.
41. Iwanaga K, Sueoka N, Sato A, Hayashi S, Sueoka E. Heterogeneous nuclear ribonucleoprotein B1 protein impairs DNA repair mediated through the inhibition of DNA-dependent protein kinase activity. Biochem Biophys Res Com 2005, 333:888-895. 10.1016/j.bbrc.2005.05.180, 15964549.
42. Ortholan C, Puissegur MP, Ilie M, Barbry P, Mari B, Hofman P. MicroRNAs and lung cancer; new oncogenes and tumor suppressors, new prognostic factors and potential therapeutic targets. Curr Med Chem 2009, 16:1047-1061. 10.2174/092986709787581833, 19275611.